Aquitaine Equity Research
Independent equity research (primarily) on U.S. mid- to mega-cap companies, written by a former buy-side analyst and CFA charterholder. AVP +47% vs. S&P 500 +13% through Sep 2026—long only, no options, no leverage.
Independent equity research (primarily) on U.S. mid- to mega-cap companies, written by a former buy-side analyst and CFA charterholder. AVP +47% vs. S&P 500 +13% through Sep 2026—long only, no options, no leverage.